Transfection Technologies Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Transfection Method (Cotransfection, Electroporation, Cationic lipid transfection, In Vivo transfection) ; Application (Virus production, Protein production, Gene silencing, Stem cell reprogramming and differentiation, Stable cell line generation) , and Geography
Request Now
MARKET INTRODUCTION
Transfection technology is an approach to produce exogenous nucleic acids such as DNA, RNA or oligonucleotide into cells. Such nucleic acids can be transferred by polymeric or lipid transfection technology reagents which promote the cellular absorption. This method is widely used for genomic studies (cell representation, testing, RNA interference, in vitro research) but can be conducted for bio-production (vaccine and protein manufacturing) or medicinal reasons (animal cell treatment). Nucleic acid delivery to cells can be accomplished by distinct physical techniques, such as electroporation, sonoporation or microinjection; however, these procedures are comparatively hazardous to cells. transfection technology with chemical substances is a better option for maintaining healthy cell feasibility.
MARKET DYNAMICS
Transfection technology market is anticipated to grow in the forecast period owing to driving factors such as the Increase in research & development in the field of cell based therapies. Moreover, rising incidences of cancer, rising investments by major players for the growing demand are also offering opportunities in the market growth during the forecast period.
MARKET SCOPE
The “Global Transfection Technology Market Analysis to 2027” is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of transfection technology market with detailed market segmentation by method, application and geography. The global transfection technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading transfection technology market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global transfection technology market is segmented on the basis of method, application. Based on method, the market is segmented as cotransfection technology, electroporation, cationic lipid transfection technology, in vivo transfection technology. Based on application, the market is segmented as virus production, protein production, gene silencing, stem cell reprogramming & differentiation and stable cell line generation.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global transfection technology market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transfection technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting transfection technology market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transfection technology market in these regions.
The report covers key developments in the transfection technology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from transfection technology market are anticipated to lucrative growth opportunities in the future with the rising demand for transfection technology in the global market. Below mentioned is the list of few companies engaged in the transfection technology market.
The report also includes the profiles of key transfection technology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific
- Lonza
- Bio-Rad Laboratories, Inc.
- Sigma Aldrich
- OZ Biosciences
- QIAGEN
- Promega Corporation
- Polyplus Transfection technology
- SignaGen Laboratories
- Mirus Bio LLC
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
